Skip to main content

Table 4 Endocrinological investigation: GHRP-2 stimulation test in January 2018 (day 8 after admission)

From: Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature

  Time (min)
0 15 30 45 60
Adrenocorticotropic hormone (pg/ml) 1.9 2.3 1.9 1.9 3.2
Cortisol (μg/dl) < 0.2 < 0.2 < 0.2 < 0.2 < 0.2
Growth hormone (ng/ml) 3.73 18.02 29.63 32.98 26.21
  1. Growth hormone-releasing peptide (GHRP)-2 (100 μg) was intravenously administered in the morning (9 a.m.)